Searched for
DRUG DISCOVERY SUBSIDIARY
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Anthropic acquires Coefficient Bio for nearly $400 million: ReportAnthropic acquires startup Coefficient Bio for about $400 million: report
- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
- Jubilant Biosys signs drug discovery pact with Finland's Orion Corporation"The research deal is aimed at developing drug that can benefit large population with unmet needs in the pain management area," Jubilant sa...
- Jubilant Chemsys, IDRI extend research for TB drug discoveryJubilant Chemsys, today announced an extension of collaborative partnership with Infectious Disease Research Institute (IDRI) for TB drug d...
- Jubilant, IDRI extend research for TB drug discoveryJubilant Chemsys, under the terms of agreement, so far had been offering philanthropic support and expertise in synthesis of NCEs to suppor...
- Biocon unit inks pact with US firm to expand collaborationBiotech firm Biocon today said its subsidiary 'Syngene International' has entered into an agreement with US-based Endo Pharmaceuticals to e...
- Merck ends pact with RanbaxySeparate reports have said the world's 2nd largest drugmaker has now shifted the research programme to Aurigine, a wholly-owned drug discov...
- Ranbaxy transfers new drug discovery unit to Daiichi SankyoRanbaxy Laboratories on Friday said it has transferred its new drug discovery research unit (NDDR) to Daiichi Sankyo India Pharma.
- Dr Reddy's announces reorganisation of its drug discovery bizDrug firm Dr Reddy's Lab (DRL) on Thursday said it will hive off its drug discovery business to a wholly-owned subsidiary, Aurigene, and wi...
- Jubilant and Orion for joint manufacture of drugsBangalore-based Jubilant Biosys and Noida-based Jubilant Chemsys have together signed an agreement with Finnish pharmaceutical company Orio...
- Jubilant Organosys in drug discovery partnership with BioLeapJubilant Organosys has entered into a drug discovery partnership with US-based BioLeap, LLC.
- Jubilant ties up with ForestJubilant Organosys has entered into an agreement with US-based Forest Laboratories for discovery of drug candidates for a metabolic disorde...
- Orchid to buy out US co Bexel PharmaOrchid Chemicals & Pharmaceuticals Ltd on Monday said it plans to buyout US-based Bexel Pharmaceuticals Inc by acquiring a 26 per cent stak...
Load More
